Understanding the essential role of monocytes in atherosclerosis

Circulation Journal

Volumn 74, Issue 7, 2010, Pages 1292-1293

  Kimura, Shinzo ^a   Sawada, Takahisa ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; MYELOPEROXIDASE; NEOPTERIN; PENTAXIN; REACTIVE OXYGEN METABOLITE; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; EDITORIAL; ENDOTHELIUM INJURY; HUMAN; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MONOCYTE; PREDICTION; PROGNOSIS; RISK FACTOR; PATHOLOGY; PHYSIOLOGY;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; MONOCYTES;

EID: 77954495160     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0469     Document Type: Editorial

References (14)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809.
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
3. Yasue H, Hirai N, Mizuno Y, Harada E, Itoh T, Yoshimura M, et al. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J 2006; 70: 8-13.
4. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
5. Nozawa N, Hibi K, Endo M, Sugano T, Ebina T, Kosuge M, et al. Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction. Circ J 2010; 74: 1384-1391.
6. Kinlay S. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol 1998; 32: 62-66.
7. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004; 43: 18-23.
8. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004; 35: 1619-1624.
9. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angio-genesis. Science 1997; 275: 964-967.
10. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: Special reference to monocyte chemoattractant protein-1. Hypertension 2003; 41: 834-841.
11. Iwai N, Kajimoto K, Kokubo Y, Okayama A, Miyazaki S, Nonogi H, et al. Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J 2006; 70: 805-809.
12. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M, et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 2005; 69: 1484-1489.
13. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001; 158: 879-891.
14. Koening W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007; 27: 15-26.